Rosaria Benedetti
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 11, 2026
Interplay between DNA and RNA methylation shapes cancer cell plasticity.
Journal: Seminars in cancer biology
Published: May 15, 2026
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells.
Journal: Bioorganic chemistry
Published: July 30, 2025
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.
Journal: Signal transduction and targeted therapy
Published: July 28, 2025
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: July 23, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.
Journal: Hepatology (Baltimore, Md.)
Published: April 17, 2025
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment.
Journal: RSC medicinal chemistry
Published: January 13, 2025
Unravelling the impact of the chromobox proteins in human cancers.
Journal: Cell death & disease
Published: December 09, 2024
"Aging and epigenetic implications in radiotherapy: The promise of BNCT".
Journal: Ageing research reviews
Published: November 21, 2024
Phase separation rewires chromatin in breast cancer.
Journal: Nature cancer
Published: October 25, 2024
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients.
Journal: ACS pharmacology & translational science
Published: July 26, 2024
Last Updated: 09/26/2026